FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 85 filers reported holding FURIEX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $12,893,000 | +22.0% | 121,432 | 0.0% | 0.01% | +12.5% |
| Q1 2014 | $10,565,000 | +90.1% | 121,432 | -8.2% | 0.01% | +100.0% |
| Q4 2013 | $5,558,000 | -19.5% | 132,311 | -15.7% | 0.00% | -33.3% |
| Q3 2013 | $6,903,000 | +22.2% | 156,922 | -5.4% | 0.01% | +20.0% |
| Q2 2013 | $5,651,000 | – | 165,863 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 349,356 | $15,368,000 | 10.66% |
| Consonance Capital Management LP | 761,764 | $33,510,000 | 8.38% |
| Global Alpha Capital Management Ltd. | 66,974 | $3,028,000 | 4.92% |
| Breithorn Capital Management | 59,158 | $2,602,000 | 1.52% |
| Artal Group S.A. | 971,051 | $42,717,000 | 1.39% |
| Montibus Capital Management LLC | 190,286 | $8,370,681,000 | 0.90% |
| THOMPSON SIEGEL & WALMSLEY LLC | 551,606 | $24,265,000 | 0.53% |
| FRANKLIN STREET ADVISORS INC /NC | 43,950 | $1,933,000 | 0.43% |
| AMERICAN CAPITAL MANAGEMENT INC | 49,392 | $2,173,000 | 0.29% |
| Spark Investment Management LLC | 28,200 | $1,240,000 | 0.28% |